Table of Contents
A patent is only valuable while the maintenance fees are paid. Miss a single annuity window and the patent expires — sometimes irreversibly. Patent annuity management is the unglamorous discipline of paying the right fee in the right jurisdiction at the right time, on a portfolio that may span 30 countries and 20 years. Done well, it quietly protects millions of dollars in patent value. Done poorly, it is the most common cause of unintended patent abandonment in the industry. Annuity decisions are also where IP portfolio optimization becomes concrete: every renewal window is a chance to stop paying for an asset that no longer earns its keep.
This guide covers what patent annuities are, how the fee schedules work in the major jurisdictions, the strategic decision of which patents to keep alive and which to abandon, and the operational practices that prevent the silent failures that lose patents to non-payment. It is written for IP managers, paralegals, and CFOs who want to understand both the mechanics and the economics.
What Are Patent Annuities?
Patent annuities — also called maintenance fees, renewal fees, or simply “annuities” depending on jurisdiction — are the periodic fees a patent holder pays to a national patent office to keep a granted patent in force. The fees are escalating: low in the early years, much higher in the later years, deliberately designed to encourage patent holders to abandon patents they no longer value.
Annuity systems differ by jurisdiction in three important ways: when fees are due, how much they are, and what grace periods exist for late payment. The U.S. uses three lump-sum maintenance fees over the life of the patent. Most other countries use annual fees that escalate year by year.
The U.S. Maintenance Fee Schedule
Under 37 CFR § 1.362, a U.S. utility patent requires three maintenance fees over its 20-year term:
| Fee | Window Opens | Window Closes | Grace Period (with surcharge) | Approx. Large-Entity Fee |
|---|---|---|---|---|
| 3.5-year | 3 years from issue | 3.5 years from issue | 3.5–4 years | ~$2,150 |
| 7.5-year | 7 years from issue | 7.5 years from issue | 7.5–8 years | ~$4,040 |
| 11.5-year | 11 years from issue | 11.5 years from issue | 11.5–12 years | ~$8,280 |
Small entity status cuts the fees by half; micro entity status cuts them by 75%. Always verify the current fee on the USPTO fee schedule, which updates roughly annually. After the grace period closes, the patent expires. Revival under 37 CFR § 1.378 is available for up to 24 months on an unintentional-delay basis, but it is not guaranteed.
European Annuities Under the EPC and National Routes
European patent annuities are paid annually starting in the third year after filing. While the application is pending at the EPO, fees are paid to the European Patent Office. After grant, the patent is validated in the chosen member states (Germany, France, UK, etc.) and annuities are paid separately to each national office. The fees escalate sharply: a patent maintained in 10 European countries through year 20 can run $200,000+ in annuity costs alone.
The new Unitary Patent (UP) system, fully operational since 2023, lets a patent holder pay a single annuity to the EPO that covers all UP-participating member states. For broad European coverage, the UP is typically cheaper than validating in 4+ countries individually. Annuity strategy now includes choosing between UP and national validation route by route.
Major Non-European Jurisdictions
- Japan (JPO): Annual fees from year 4, escalating; relatively predictable schedule.
- China (CNIPA): Annual fees from year 1 of grant; among the lower-cost major jurisdictions.
- Korea (KIPO): Annual fees from year 4; mid-range cost.
- Canada: Annual fees from year 2; small-entity status available.
- India: Annual fees on a tiered schedule; recent fee increases for non-startup entities.
- Brazil (INPI): Annual fees from year 3; historically slow to process payment confirmations.
The Strategic Side: Pruning the Portfolio
The escalating fee schedule is a feature, not a bug. It exists to push patent holders to make deliberate keep-or-abandon decisions on each patent at each renewal. The most expensive mistake in annuity management is paying the 11.5-year U.S. fee or the year-15 European fees on patents that the business no longer values.
Best-in-class portfolio management runs an annual review on every patent approaching a major renewal window. The review asks four questions:
- Is the patented technology still in any product or service the company sells?
- Is the patent licensed or part of a defensive cross-license?
- Is the patent likely to be asserted offensively in the next five years?
- Could the patent be sold to another party?
If all four answers are no, the patent should be abandoned. The savings on a single mid-tier U.S. patent abandoned at year 7 vs. carried to year 12 can run $10,000+ once foreign annuities are factored in.
Timing matters as much as the decision itself. Run the keep-or-abandon review three to four months before each fee window opens, not on the deadline. That lead time leaves room to explore a sale or license to a third party — an unused patent that is worthless to your business may still be worth five figures to a competitor or a defensive patent aggregator — and it keeps the abandonment from becoming a last-minute default that nobody consciously chose.
Operational Practices That Prevent Silent Failures
Annuity management has more silent-failure modes than almost any other docketing function. Unlike Office Actions, an annuity that does not get paid does not generate any further correspondence — the patent simply lapses. The defensive practices below are the difference between a clean portfolio and one with three abandoned patents nobody knew about until a competitor’s lawyer pointed it out.
- Pull provider reports monthly. Reconcile every “paid,” “pending,” and “abandoned” status against the master docket.
- Confirm intent on every abandonment. Every patent the provider marks as abandoned for non-payment should match an explicit client decision in writing.
- Use multiple reminders. 90-day and 30-day reminders to the responsible attorney and the client portfolio owner are the minimum.
- Track payment confirmations. The annuity is not “paid” until the foreign office confirms receipt — not when the provider sends the wire.
- Audit foreign agent records. Annually, sample 5–10% of foreign agent records and confirm the firm’s docket matches.
In-House vs. Outsourced Annuity Payment
Almost no IP firm or corporate IP team handles foreign annuity payments in-house. The economics do not work: setting up wire transfer relationships with 30+ foreign offices, dealing with currency conversion, and managing local-agent fees is operationally heavier than just paying a specialist provider. Computer Packages Inc. (CPI), Dennemeyer, and Patent Renewal Center are the dominant providers. Most enterprise platforms (Anaqua, Foundation IP) include native annuity payment as part of the docketing system.
The decision is less about who pays the fees and more about who reconciles the payments back into the master docket. That is where most firms underinvest, and where the audit gap shows up. The same build-versus-buy logic that governs the whole docketing function applies here; our analysis of whether to outsource patent docketing lays out when each model makes sense, and a docketing audit is what surfaces the reconciliation gaps before they cost a patent.
The Cost of Getting It Wrong
The realistic loss from a single missed annuity on a high-value patent depends on the licensing or product revenue tied to the patent, but a useful baseline is the cost of acquiring an equivalent replacement patent: typically $25,000–$50,000 in prosecution costs and three to five years of pendency. For patents tied to a flagship product, the loss can be measured in millions of dollars of competitive freedom-to-operate exposure.
The defensive cost — rigorous annuity management — is comparatively trivial: typically 1–3% of total annuity spend.
Building a Patent Annuity Management Workflow That Does Not Fail
Portfolios are rarely lost because someone decided to let a patent go. They are lost because an instruction was sent and never confirmed, or because a record was accurate in 2021 and nobody checked it since. Good patent annuity management is therefore less about calendars than about verification.
Keep two independent records, and reconcile them. Your docketing system is a statement of what you believe is true. The official register is what the office believes. Those two drift, and the drift is invisible until a renewal fails. Reconcile the full portfolio against the USPTO maintenance fee records and the European Patent Register at least annually, and against national registers wherever a validated European patent sits.
A reminder is not a payment. The most common silent failure in the whole discipline is a docket closed on the instruction rather than on the receipt. An instruction can be sent to a lapsed agent, bounce from a dead mailbox, or be received and not actioned. Only the official receipt proves payment, and the docket should not close without it.
Treat the grace period as an incident, not a buffer. Escalation should begin well before the ordinary due date, with a named owner at each step and a hard stop that triggers before the surcharge window opens. Teams that routinely pay inside the grace period have normalised the state that precedes a loss.
Watch the events that break the chain. Most lapses trace to an administrative change rather than a missed date:
- Assignments and acquisitions. The old agent stops paying because the matter moved; the new agent was never formally instructed. Annuities disappear into the gap between them.
- Address for service changes. Office correspondence continues to a superseded address and the first anyone hears of a problem is the lapse notice.
- Agent and firm changes. Powers of attorney are updated on live prosecution matters and forgotten on granted cases, which generate no other correspondence.
- Entity status changes. Losing small or micro entity status on growth, or a licence to a large entity, changes the fee owed – and paying the wrong amount can be as damaging as paying nothing.
- Register recordal gaps. Ownership recorded in your system but never recorded at the office leaves the office dealing with a party that no longer exists.
Make the keep-or-abandon decision early. Budget the annuity run twelve months ahead and route the expensive later-stage fees to a business owner for an explicit decision. Patent annuity management done well does not merely pay on time; it makes abandonment a deliberate choice rather than an accident, which is the only way the escalating fee schedule works as intended.
Missing a European Deadline: Rule 51(2) EPC and Re-establishment
European practice deserves separate treatment, because the remedies are markedly less forgiving than the United States equivalents and the structure changes at grant.
While a European application is pending, renewal fees are payable to the EPO in respect of the third year onwards, in advance. If the fee is not paid by the due date, Rule 51(2) EPC allows it to be paid within six months of that date provided an additional fee is paid at the same time – an uplift of fifty per cent of the renewal fee. That six-month window is the ordinary safety net, and it is the last routine opportunity.
What follows is the part that surprises people. Further processing under Article 121 EPC, which rescues most missed EPO time limits almost automatically, is not available to extend the Rule 51(2) period. The remaining route is re-establishment of rights under Article 122 EPC, and that requires the applicant to show it took all due care required by the circumstances.
All due care is a demanding standard. It contemplates a properly designed system with an independent cross-check that failed despite reasonable supervision – an isolated mistake inside an otherwise sound process. A docketing failure that cannot be explained, or a system with no second check at all, generally does not meet it. Compare that with the United States, where a delayed maintenance fee may be accepted under 37 CFR 1.378 on a showing that the delay was unintentional. The practical gap between the two standards is wide, and a portfolio run to the American standard will eventually lose a European case.
After grant the picture changes shape entirely. A classical European patent becomes a bundle of national rights, and renewals are then paid to each national office under its own schedule, its own grace period and its own restoration rules. A unitary patent, by contrast, carries a single renewal fee paid centrally to the EPO – which is one of its genuine administrative attractions, and a point worth weighing when choosing between the two routes.
The operational consequence for patent annuity management is that the European leg needs tighter controls than the rest of the portfolio, not the same ones. Build the second check that Article 122 expects before you need to rely on it, because the evidence for all due care is the system you had in place at the time, not the explanation you construct afterwards.
Conclusion
Patent annuity management lives at the intersection of operational discipline and portfolio strategy. The operational side is well understood and well templated. The strategic side — deciding which patents to keep alive at year 7, year 12, year 15 — is where most firms leave money on the table by paying renewal fees on patents that should have been pruned. Both sides have to be running well for the portfolio to compound value.
For the broader docketing context, see what patent docketing is and patent docketing best practices.
Want a portfolio annuity audit? Contact Perspire IP for a no-cost review of your current renewals against business-value criteria.
Frequently Asked Questions
What is a patent annuity?
A patent annuity (also called a maintenance fee or renewal fee) is the periodic fee a patent holder pays to a national patent office to keep a granted patent in force. Most jurisdictions charge annual fees on an escalating schedule; the United States uses three lump-sum fees at 3.5, 7.5, and 11.5 years from issue.
What happens if a patent annuity is not paid?
The patent expires. In the U.S., the grace period under 37 CFR § 1.362 lets the holder pay the fee plus a surcharge for six months past the original due date. After that, revival under 37 CFR § 1.378 is possible for up to 24 months on an unintentional-delay basis but requires a petition.
How do I decide whether to keep a patent alive?
Run an annual review against four questions: is the patented technology still in any product or service we sell, is it licensed or part of a defensive cross-license, is it likely to be asserted offensively in the next five years, and could it be sold? If all four are no, abandon.
Should we use a third-party annuity provider?
For foreign annuities, almost always yes. The infrastructure to wire fees to 30+ foreign offices in local currency is not worth building in-house. CPI, Dennemeyer, and Patent Renewal Center are the dominant providers; many docketing platforms (Anaqua, Foundation IP) include native annuity service.
How much does foreign annuity coverage cost?
Highly variable by jurisdiction and patent age. As a rough planning number, a patent maintained through year 20 in 10 major jurisdictions can run $150,000–$250,000+ in cumulative annuity fees alone, before agent and provider fees.
Citations & Authorities
- 37 CFR § 1.362 (U.S. maintenance fee schedule).
- 37 CFR § 1.378 (revival of patents abandoned for non-payment).
- USPTO Fee Schedule, available at uspto.gov.
- European Patent Office, “Renewal fees,” available at epo.org.
- Computer Packages Inc., “Patent Annuity Management,” available at computerpackages.com.
- Anaqua, “Patent Annuity and Trademark Renewal Services,” available at anaqua.com.
- Dennemeyer, “Patent Renewals & Patent Maintenance Service,” available at dennemeyer.com.